COVID-19 Pandemic

Sponsored Projects Administration is fully functional and operating at normal capacity even though the University has suspended on-site operations for purposes of decreasing COVID-19 transmission.

Information and Resources for Researchers:

• Funding opportunities related to COVID-19:

• NIH: Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)
• NIH: Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
• NSF Rapid Response proposals:https://www.nsf.gov/pubs/2020/nsf20052/nsf20052.pdf
• DOD: MTEC funding pre-announcement for Diagnostics, therapeutics, Disease modeling, Patient Monitoring
• MIT: Health Security and Pandemics Challenge ($1 million) Solution pitch due 6.18.2020
• NIH/NIDA: (NOSI) for Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (Risk factors for HIV-affected and Substance abuse disorder populations)
• BARDA:  https://beta.sam.gov/opp/1b46a4169fcb4902b9c4fcbb5bf981f7/view
• NIH: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-028.html
• NSF: https://www.nsf.gov/pubs/2020/nsf20055/nsf20055.jsp
• CDC: https://beta.sam.gov/opp/728e1131ef444abc880f63540a37c364/view?keywords=...
• DARPA’s FAQs encourages performers with research project ideas related to COVID-19 to respond to the Office-wide broad agency announcements (BAAs) for both the Defense Sciences Office (DSO) and Biological Technology Office (BTO), which both have open BAAs that can receive submissions at any time. The DSO and BTO Office-wide BAAs can be found at https://www.darpa.mil/work-with-us/office-wide-broad-agency-announcements

• HHS/Biomedical Advanced Research and Development Authority (BARDA)

  BARDA opened an easy broad agency announcement, an EZ-BAA, seeking diagnostics that utilize platforms already cleared by the FDA, with a viable plan to meet requirements for the FDA to consider emergency use authorization within 12 weeks.

• NIH/National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of General Medical Sciences (NIGMS)
  

  Administrative Supplementals Current grantees may be eligible to apply for an administrative supplemental. Contact your program officer to discuss proposed research on SARS-CoV-2/COVID-2019. If it is within the scope of your current grant, an administrative supplement is the best option to obtain additional funding. PA-18-591

• NIH/NIGMS: Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 https://grants.nih.gov/grants/guide/notice-files/NOT-GM-20-025.html

• NIH/NIAID: Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease,  https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-034.html

• NIGMS Feedback Loop: https://loop.nigms.nih.gov/2020/03/urgent-competitive-revisions-to-nigms...

• AHRQ: Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19

• American Heart Association: Rapid Response Grants for Heart and Brain Focused Research related to COVID-19

• NIH: NOT-AI-20-034 Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-1 https://grants.nih.gov/grants/guide/notice-files/NOT-AI-20-034.html

• NIH: NOT-TR-20-011 Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need https://grants.nih.gov/grants/guide/notice-files/NOT-TR-20-011.html

• NIH PA-20-135 Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PA-20-135.html

• NIH NOT-EB-20-003 Notice of NIBIB's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)" https://grants.nih.gov/grants/guide/notice-files/NOT-EB-20-003.html

• NSF: On March 25, NSF released a Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19. NSF invites U.S.-based businesses to submit Phase I SBIR/STTR proposals focused on “the development and deployment of new technologies, products, processes, and services” that have the potential to help respond to COVID-19. The DCL highlights the following areas of research: artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations. The DCL is available at https://www.nsf.gov/pubs/2020/nsf20065/nsf20065.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click

• NIH/NIA/NIMH:  Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) https://grants.nih.gov/grants/guide/notice-files/NOT-AG-20-022.html

• Russel Sage Foundation:  Funds to study social, political, economic, or psychological disruptions resulting from the coronavirus crisis that affect social and living conditions in the United States;  https://www.russellsage.org/how-to-apply/application-deadlines

• Tulane FAQs for Federal Grant Applicants and Award Recipients During the COVID-19 Pandemic

• Sponsor Guidance for federal applicants and grantees:

  • NIH https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

  • NSF:  https://www.nsf.gov/news/special_reports/coronavirus/

  • NEA: https://www.arts.gov/coronavirus

  • NEH: https://www.neh.gov/news/information-neh-and-covid-19

  • DOE: https://www.energy.gov/coronavirus-hub

  • DoEd: https://www.ed.gov/coronavirus?src=feature

  • DOJ:  Sends you to CDC: https://www.coronavirus.gov/

  • OMB: Sends you to CDC; https://www.coronavirus.gov/

  • LaBOR: https://regents.la.gov/covid19-response/

  • DOD: https://basicresearch.defense.gov/COVID-19/Frequently-Asked-Questions/

• Sponsored Projects Administration (SPA) provides both pre and post award services to the Tulane University research community. SPA maintains listservs through which it targets Tulane faculty working in broad disciplinary areas for upcoming funding opportunities and internal competitions. At the proposal stage SPA staff work with faculty and departmental administrators to assist with budget development, interpret sponsor guidelines, file required compliance documents and provide authorized institutional approvals through signatures or the electronic proposal submission process.
• SPA also reviews all awards made to Tulane University and if necessary, engages in fiscal and business negotiations with sponsors to ensure compliance with university policies and federal regulations. SPA staff are authorized to execute research agreements (i.e. contracts, subcontracts, cooperative agreements, clinical trial agreements, etc.) and issue all required subagreements to collaborating institutions when required. Additionally, certain administrative and fiscal compliance requirements associated with the post-award and close-out phases of sponsored projects are administrated by this office.